The Scientist’s Top 10 Scientific Innovations for 2014 Offer Powerful New Research Tools to Advance Diagnostics and Possibly Find Uses in Clinical Laboratories

Many of these new technologies could help pathologists develop new diagnostic tests and offer medical laboratories opportunities to expand their services Pathologists and clinical laboratory scientists tracking the hottest new diagnostic technologies may be in interested in the 2014 list of “Top Ten Innovations” recently published by The Scientist. This is a competition and each year The Scientist has a panel of five experts in life sciences review the entries. Among this year’s Top Ten...

Beckman Coulter Acquired by Danaher as In Vitro Diagnostics Industry Consolidates

Clinical pathology laboratory customers of Beckman Coulter shouldn’t see major changes Yesterday came news that Danaher Corporation (NYSE: DHR) of Washington, D.C., would acquire Beckman Coulter, Inc., (NYSE: BEC) of Brea, California, in a transaction valued at $6.8 billion. Beckman is among the world’s larger manufacturers of in vitro diagnostics (IVD) analyzers and automation for clinical pathology laboratories. For pathologists and medical laboratory administrators, the significance of the...

Pathology Companies Leica and Omnyx Beef Up Their Access to Digital Pathology Technology

Leica Microsystem acquires Genetix while Omnyx licenses patents from Olympus More pathology laboratories are acquiring and deploying digital scanners and digital pathology systems. In response to the growing demand for digital pathology solutions, several prominent companies are extending their capabilities in virtual microscope slide technology. Over recent months, an acquisition and a licensing deal provide examples of the intense activity in the digital pathology marketplace. The...
;